More African nations are expected to approve the malaria vaccine.

Published Date: 25 Apr 2023

With 20 million doses of a new malaria vaccine on the market for them to purchase this year, African nations are lining up to approve it.

Read Full News

Latest News

Medicaid expansion increases access to HIV prevention medication for high-risk populations

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis who were prescribed preexposure prophylaxis (PrEP), a preventative medication taken in pill or injectable ...

Pneumocystis pneumonia is striking unexpected patient groups, study shows

A seven-year study of 470 patients revealed that a severe fungal lung infection once mainly seen in specific high-risk groups is increasingly affecting elderly patients and those with common cancers who are not receiving ...

Ethiopia confirms 3 Marburg virus deaths in new outbreak

Ethiopia on Monday confirmed three deaths from the Marburg hemorrhagic virus that has been detected in an area neighboring South Sudan.

Keto diet stops a young girl's epileptic seizures

Alana "Lani" Silverberg was a real firecracker with a big personality at age 3—until she started having seizures.

High disease burden found among at-risk Medicaid beneficiaries

Over 40% of the 5 million people at risk of losing Medicaid coverage due to new eligibility requirements have at least three chronic health conditions, and older adults are especially vulnerable, a new JAMA study shows.

Trial evaluates a vitamin B3 derivative in people with long COVID

Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These symptoms can affect people of all ages and often include neurological issues such as "brain fog," ...

Todays Updates

FDA Grants Priority Review to Efgartigimod, First Potential Therapy for Seronegative Myasthenia Gravis Victoria Johnson

argenx's efgartigimod-alfa therapy was approved for seropositive generalized myasthenia gravis in 2021.

Early Opicapone Initiation in Parkinson Leads to Continued Long-Term Therapeutic Benefits Marco Meglio

Early initiation of opicapone significantly reduces OFF time and enhances ON time in patients with recently diagnosed Parkinson's disease, improving overall treatment outcomes.

FDA Requests HOPE-3 Clinical Study Report for Deramiocel BLA in DMD Cardiomyopathy Isabella Ciccone, MPH

The FDA requested the full data from the phase 3 HOPE-3 study as part of its review of the biologics license application for deramiocel, which Capricor plans to submit in February 2026.

Low-Dose Opioids Show Long-Term Dose Stability, Effectiveness in Augmented Restless Legs Syndrome Louie Pasculli

A five-year analysis from the National RLS Opioid Registry found that most patients with dopamine agonist augmented restless legs syndrome maintained stable, low-dose opioid therapy with sustained symptom control.

Personalized Care Improvements Identified for Older Patients with Skin Cancer

Personalized Care Improvements Identified for Older Patients with Skin Cancer

New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc

New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc

What to Expect at the 2026 Maui Derm Conference

What to Expect at the 2026 Maui Derm Conference

Todays Updates

FDA Grants Priority Review to Efgartigimod, First Potential Therapy for Seronegative Myasthenia Gravis Victoria Johnson

argenx's efgartigimod-alfa therapy was approved for seropositive generalized myasthenia gravis in 2021.

Early Opicapone Initiation in Parkinson Leads to Continued Long-Term Therapeutic Benefits Marco Meglio

Early initiation of opicapone significantly reduces OFF time and enhances ON time in patients with recently diagnosed Parkinson's disease, improving overall treatment outcomes.

FDA Requests HOPE-3 Clinical Study Report for Deramiocel BLA in DMD Cardiomyopathy Isabella Ciccone, MPH

The FDA requested the full data from the phase 3 HOPE-3 study as part of its review of the biologics license application for deramiocel, which Capricor plans to submit in February 2026.

Low-Dose Opioids Show Long-Term Dose Stability, Effectiveness in Augmented Restless Legs Syndrome Louie Pasculli

A five-year analysis from the National RLS Opioid Registry found that most patients with dopamine agonist augmented restless legs syndrome maintained stable, low-dose opioid therapy with sustained symptom control.

Personalized Care Improvements Identified for Older Patients with Skin Cancer

Personalized Care Improvements Identified for Older Patients with Skin Cancer

New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc

New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc

What to Expect at the 2026 Maui Derm Conference

What to Expect at the 2026 Maui Derm Conference

Latest News

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis who were prescribed preexposure prophylaxis (PrEP), a preventative medication taken in pill or injectable ...

A seven-year study of 470 patients revealed that a severe fungal lung infection once mainly seen in specific high-risk groups is increasingly affecting elderly patients and those with common cancers who are not receiving ...

Ethiopia on Monday confirmed three deaths from the Marburg hemorrhagic virus that has been detected in an area neighboring South Sudan.

Alana "Lani" Silverberg was a real firecracker with a big personality at age 3—until she started having seizures.

Over 40% of the 5 million people at risk of losing Medicaid coverage due to new eligibility requirements have at least three chronic health conditions, and older adults are especially vulnerable, a new JAMA study shows.

Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These symptoms can affect people of all ages and often include neurological issues such as "brain fog," ...

News All Time

Researchers to test gene therapy for rare diseases with a new FDA trial protocol

Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a rare liver disorder.

Monoclonal antibodies effectively prevent respiratory syncytial virus in infants

Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the respiratory virus season. However, especially among young infants under six months of age or people ...

Preliminary case of bird flu in Washington state would be U.S.'s first in 9 months

Health officials in Washington state say they have identified the nation's first human case of bird flu since February, pending confirmatory testing.

Overlooked layer of DNA may explain disease risk, severity

Scientists at The Hospital for Sick Children (SickKids) have revealed a previously overlooked layer of genetic variation that could help explain why people experience disease differently, and why some treatments work better ...

Reversing fibrosis: New research provides insight for novel therapies

Yale School of Medicine (YSM) researchers have made key breakthroughs in understanding how to treat fibrotic diseases such as scleroderma and graft-versus-host disease.

Ethiopia confirms first Marburg outbreak as WHO lauds country's fast action

Ethiopia on Friday confirmed its first Marburg outbreak after nine cases were identified in a southern region of the country that borders South Sudan.

Metabolic hormone found to boost resilience against flu symptoms

A hormone known for regulating energy balance also helps the body cope with influenza by triggering protective responses in the brain, a study led by UT Southwestern Medical Center researchers shows.

Measles case confirmed in southwestern Colorado, possible exposures in Cortez, Mancos

People in Cortez and Mancos may have been exposed to the measles from a confirmed case in a school-aged child in Montezuma County, according to the Colorado Department of Public Health and Environment.

Typhoid conjugate vaccine demonstrates strong safety and immunogenicity in Phase III trial

Phase III results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj. Multi-dose, demonstrate that it is safe and immunogenic in typhoid-endemic populations in sub-Saharan Africa. EuTYPH-C Inj. Multi-dose ...

First death linked to 'meat allergy' spread by ticks

University of Virginia School of Medicine researchers have identified the first death caused by what is commonly called the "meat allergy" being spread by ticks.

Testing lung function earlier may help identify risk for COPD

Measuring lung function earlier in life would help identify people at risk of developing chronic obstructive pulmonary disease (COPD) and allow for more timely interventions, according to a new study published in the September ...

Ethiopia investigates possible outbreak of new viral hemorrhagic fever after 8 people are infected

African health authorities on Thursday confirmed a possible outbreak of an unidentified viral hemorrhagic fever in southern Ethiopia that is under investigation after eight suspected cases were reported.

COP30 report reveals how climate change is spreading infectious diseases to new regions

Rising temperatures, changing rainfall patterns and extreme weather events create ideal conditions for pathogens and their vectors—such as mosquitoes, midges and ticks—to thrive.

Headaches affect almost a third of people worldwide

Do you have regular migraine headaches? If so, you've got a lot of company.

Stinky socks help replace human bait in surveys for river blindness

New research shows that it's possible to end the practice of using people as human bait to catch and test the black flies that spread river blindness (onchocerciasis). The study by international non‐profit Sightsavers in ...

Q&A: Why experts urge continued hepatitis B vaccine birth doses for newborns

In a commentary published in Gastroenterology, leading experts urge that all newborns in the United States continue to receive the first dose of hepatitis B vaccine within 24 hours of birth.

Recommended News For You

A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma

Unraveling the role of exercise in cancer suppression

An Eye Surgeon's Unexpected Discovery of the "Before and After".

Targeted radiation therapy shows near-complete response in rare sarcoma patients

Immunotherapy and targeted radiation shrink liver tumors, enabling surgery

Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death

A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.

Recommended Articles For You

Uncovering the Subtle Signs of Prostate Cancer: Early Detection is Key 

Unveiling the Hidden Causes of Anemia: A Comprehensive Look at a Common Condition 

Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor 

Decoding Efficacy, Safety, and Future Frontiers in CAR-T Cell Therapy for Hematologic Malignancies Towards CAR-T Therapy 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Treatment of Smoldering Myeloma Cuts Progression Rate in Half

2.

The Benefits of Exercise for Substance Use Disorders.

3.

Microplastics can cause malignant changes in lung cells

4.

Medical Journal March 29, 2023

5.

According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.

1.

Studying Lactic Acid in Pediatric Tumor Microenvironments: Experimental Approaches Explored

2.

The Importance of Balanced Potassium Levels in Maintaining Good Health

3.

Cowden Syndrome and Cancer: Understanding the Risk Factors 

4.

Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment

5.

An Overview Of Daunorubicin: What Is It Used For And How Does It Work?

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

2.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

3.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

5.

Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot